Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-026135
Filing Date
2022-04-29
Accepted
2022-04-29 12:58:09
Documents
1
Period of Report
2022-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7290
  Complete submission text file 0001209191-22-026135.txt   8620
Mailing Address 1207 17TH AVENUE SUITE 103 NASHVILLE TN 37212
Business Address
KAZIMI A J (Reporting) CIK: 0001075050 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33637 | Film No.: 22872816

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations